Skip to main content

Share or Save this page

New Damage Control Resuscitation CPG Now Available

The JTS has published the updated Damage Control Resuscitation (DCR) Clinical Practice Guideline (CPG) filled with life-saving recommendations based on the latest research and best practices built on lessons learned on the frontlines and in medical treatment facilities. Below is a summary of changes found in the DCR CPG.

  • Greater emphasis on the use of Low Titer O Whole Blood
  • Updated risk factors for massive transfusion
  • Earlier use of calcium use recommended for hemorrhagic shock (with transfusion) and for ongoing resuscitation
  • Adjusted blood pressure goals for DCR for traumatic brain injury
  • Resuscitative Endovascular Balloon Occlusion of the Aorta updated as a fielded option for the control of non-compressible torso hemorrhage by resuscitation teams.
  • The discontinued use of hydroxyethyl starch (i.e. Hextend, Hespan) as a resuscitation fluid
  • The discontinued use of recombinant human activated factor VII


back to top
Last Modified Date: 10/27/2020